Results of All-Trans Retinoic Acid Treatment in Acute Promyelocytic Leukemia (European Experience)
暂无分享,去创建一个
[1] P. Fenaux,et al. Retinoic Acid Syndrome , 1998, Drug safety.
[2] H. Dombret,et al. All-trans-retinoic acid as a differentiating agent in the treatment of acute promyelocytic leukemia. , 1995, Blood.
[3] M. Fey,et al. Prolonged follow-up confirms that all-trans retinoic acid followed by chemotherapy reduces the risk of relapse in newly diagnosed acute promyelocytic leukemia. The French APL Group [letter] , 1994 .
[4] M. Fey,et al. Prolonged follow-up confirms that all-trans retinoic acid followed by chemotherapy reduces the risk of relapse in newly diagnosed acute promyelocytic leukemia. The French APL Group. , 1994, Blood.
[5] N. Tsukada,et al. Fatal thromboembolism in acute promyelocytic leukemia during all-trans retinoic acid therapy combined with antifibrinolytic therapy for prophylaxis of hemorrhage. , 1994, Leukemia.
[6] N. Stuurman,et al. The t(15;17) translocation alters a nuclear body in a retinoic acid‐reversible fashion. , 1994, The EMBO journal.
[7] P. Fenaux,et al. Effect of all transretinoic acid in newly diagnosed acute promyelocytic leukemia. Results of a multicenter randomized trial. European APL 91 Group , 1993 .
[8] H. de Thé,et al. PML protein expression in hematopoietic and acute promyelocytic leukemia cells. , 1993, Blood.
[9] R. Warrell,et al. Acute promyelocytic leukemia. , 1993, The New England journal of medicine.
[10] J. Lacerda,et al. Multiple thrombosis in acute promyelocytic leukaemia after tretinoin , 1993, The Lancet.
[11] H. Dombret,et al. All-transretinoic acid followed by intensive chemotherapy gives a high complete remission rate and may prolong remissions in newly diagnosed acute promyelocytic leukemia: a pilot study on 26 cases. , 1992, Blood.
[12] R. Warrell,et al. The "Retinoic Acid Syndrome" in Acute Promyelocytic Leukemia , 1992, Annals of Internal Medicine.
[13] C. Chomienne,et al. Induction of retinoic acid-binding protein in normal and malignant human myeloid cells by retinoic acid in acute promyelocytic leukemia patients. , 1992, Cancer research.
[14] A. Dejean,et al. A PML/retinoic acid receptor alpha fusion transcript is constantly detected by RNA-based polymerase chain reaction in acute promyelocytic leukemia. , 1992, Blood.
[15] R. Warrell,et al. Clinical pharmacology of oral all-trans retinoic acid in patients with acute promyelocytic leukemia. , 1992, Cancer research.
[16] H. Dombret,et al. Treatment of first relapse in acute promyelocytic leukaemia with all-trans retinoic acid , 1990, The Lancet.
[17] R Berger,et al. All-trans retinoic acid as a differentiation therapy for acute promyelocytic leukemia. I. Clinical results. , 1990, Blood.
[18] P. Fenaux,et al. All-trans retinoic acid in acute promyelocytic leukemias. II. In vitro studies: structure-function relationship. , 1990, Blood.
[19] Christine Chomienne,et al. The t(15;17) translocation of acute promyelocytic leukaemia fuses the retinoic acid receptor α gene to a novel transcribed locus , 1990, Nature.
[20] Zhen-yi Wang,et al. Use of all-trans retinoic acid in the treatment of acute promyelocytic leukemia. , 1988, Haematology and blood transfusion.
[21] H. Gralnick,et al. Proposals for the Classification of the Acute Leukaemias French‐American‐British (FAB) Co‐operative Group , 1976, British journal of haematology.
[22] M. Boiron,et al. Acute promyelocytic leukemia: results of treatment by daunorubicin. , 1973, Blood.
[23] H. Dombret,et al. Coagulation disorders associated with acute promyelocytic leukemia: corrective effect of all-trans retinoic acid treatment. , 1993, Leukemia.
[24] H. Dombret,et al. All trans retinoic acid treatment for patients with acute promyelocytic leukemia. , 1992, Leukemia.
[25] M. Flint. Letter: Pathogenesis of osteoarthrosis. , 1974, Lancet.